FrederickAlticeMD

Infectious Disease • New Haven, CT

HIV/AIDS Medicine, International Health, Travel & Tropical, STD Medicine

Professor of Medicine and Public Health, Yale University

Join to view full profile

Dr. Altice is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Altice's full profile

Already have an account?

Office
789 Howard Ave
Dana Bldg 3RD FL
New Haven, CT 06519
Phone+1 203-785-4140

Fax+1 203-737-4051

Summary

Dr. Frederick Altice is an infectious diseases and addiction medicine specialist in New Haven, CT and is affiliated with multiple hospitals in the area, including Yale-New Haven Hospital, Veterans Affairs Connecticut Healthcare System, and Yale New Haven Hospital. He received his medical degree from Emory University School of Medicine and has been in practice over 30 years. He also speaks multiple languages, including Spanish. He specializes in global health, infectious diseases, HIV, viral hepatitis, tuberculosis, and STIs. He is an expert in implementation science, behavioral and biomedical treatment and prevention interventions, mHealth development and testing and decision science. He oversees research centers in the U.S., Malaysia, Ukraine and Peru and is co-director of the Fogarty International Training Center for Implementation Science at University of Malaya. He has joint faculty appointments at University of Malaya and Sichuan University.

Education & Training

Yale-New Haven Medical CenterFellowship, Infectious Disease, 1990 - 1992
Yale-New Haven Medical CenterResidency, Internal Medicine, 1986 - 1989
Emory University School of MedicineClass of 1986

Certifications & Licensure

CT State Medical License 1990 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

Buprenorphine and Integrated HIV Care Evaluation Start of enrollment: 2005 Aug 01
Unknown status
Phase 4
Improving Treatment Adherence in HIV-Infected Individuals Start of enrollment: 2005 Oct 01
Completed
Phase 2
Directly Observed Antiretroviral Therapy Among Active Drug Users Start of enrollment: 2001 Jun 01
Completed
Not Applicable
Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance Start of enrollment: 2003 Oct 01
Completed
Not Applicable
Early Versus Delayed Routine HIV Testing in Connecticut Jails Start of enrollment: 2007 Aug 01
Completed
Early Phase 1
Directly Observed Therapy for Community-Released HIV+ Prisoners Start of enrollment: 2004 Jul 01
Completed
Not Applicable
Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) Start of enrollment: 2005 Aug 01
Completed
Phase 4
Positive Lifestyles Using Safety Start of enrollment: 2008 Jan 01
Completed
Not Applicable
Transitions: Linkages From Jail To Community Start of enrollment: 2008 Sep 01
Completed
Not Applicable
Alcohol Pharmacotherapy for HIV+ Prisoners Start of enrollment: 2010 Aug 01
Completed
Not Applicable
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations Start of enrollment: 2011 Mar 01
Completed
Phase 1, Phase 2
Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder Start of enrollment: 2014 May 01
Completed
Phase 4
HIV, Buprenorphine, and the Criminal Justice System Start of enrollment: 2012 Feb 23
Completed
Not Applicable
Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus Start of enrollment: 2012 Nov 01
Completed
Not Applicable
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia Start of enrollment: 2010 Jan 01
Completed
Phase 4
Project BEST: Buprenorphine Entry Into Substance Abuse Treatment Start of enrollment: 2005 May 01
Completed
Comparative Evaluation of PUSPENs and C&Cs Start of enrollment: 2012 Aug 01
Terminated
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings Start of enrollment: 2017 Aug 21
Active, not recruiting
Not Applicable
HIV, Buprenorphine, and the Criminal Justice System (STRIDE2) Start of enrollment: 2014 Jun 23
Completed
EPIC-P Intervention Start of enrollment: 2020 Sep 15
Completed
Not Applicable
Peer-led Social Media Intervention to Prevent HIV Among Young Men Who Have Sex With Men (YMSM) Start of enrollment: 2018 Jun 05
Completed
Not Applicable
Project SMART Automated Pillbox Study Start of enrollment: 2017 Jun 08
Completed
Not Applicable
Expanding Medication-Assisted Therapies in Central Asia Start of enrollment: 2023 Aug 07
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

25 citations
Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine.
Lynn M. Madden, Martha J. Bojko, Scott O. Farnum, Alyona Mazhnaya, Tatiana Fomenko
The International Journal on Drug Policy. 2017-11-01
68 citations
Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study.
Jaimie P. Meyer, Alexei Zelenev, Jeffrey A. Wickersham, Chyvette T. Williams, Paul A. Teixeira
American Journal of Public Health. 2014-02-12
104 citations
Neurocognitive Impairment and HIV Risk Factors: A Reciprocal Relationship
Pria Anand, Sandra A. Springer, Michael M. Copenhaver, Frederick L. Altice
AIDS and Behavior. 2010-03-16

Journal Articles

Adherence to Antiretroviral Therapy Among Incarcerated Persons with HIV: Associations with Methadone and Perceived Safety
Frederick Altice, MD, AIDS and Behavior
Retention in HIV Care During the 3 Years Following Release from Incarceration: A Cohort Study
Frederick L Altice, Kelsey B Loeliger, Jaimie P Meyer, PLoS One
Pre-Exposure Prophylaxis Among Men Who Have Sex with Men: Dual Motivational Model of Intention to Use Pre-Exposure Prophylaxis
Liana Fraenkel, Kenneth Mayer, Frederick L Altice, AIDS and Behavior
Assessment of Barrier Severity and Willingness to Enter Opioid Agonist Treatment Among People Who Inject Drugs in Ukraine
Frederick Altice, MD, Drug and Alcohol Dependence
Join now to see all

Authored Content

Assessment of Barrier Severity and Willingness to Enter Opioid Agonist Treatment Among People Who Inject Drugs in UkraineJuly 2018
Hepatitis C Virus Status Awareness and Test Results Confirmation Among People Who Inject Drugs in UkraineJune 2018

Press Mentions

New Haven Plans for Late Summer Distribution of NarcanApril 21st, 2023
HIV/AIDS Care at YaleMay 18th, 2022
Discoveries & Impact (May 2022)May 12th, 2022
Join now to see all

Grant Support

Integrating Addiction and Infectious Diseases Services into Primary Care in Rural SettingsNIDA2021–2026
Malaysian Implementation Science Training (MIST) Program in HIVFogarty International Center2020–2025
Developing an artificial intelligence-based mHealth intervention to increase HIV testing in MalaysiaNIDA2020–2025
Vitamin D and Alcohol Use Disorder on Progression of Dental Disease in MSM with and without HIVNIDCR2021–2023
Modeling the impact and cost-effectiveness of opioid agonist treatments to reduce the negative consequences of incarceration on HIV and TB transmission in Eastern Europe and Central AsiaNIDA2021–2023
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in UkraineNIDA2018–2023
INTEGRATING TREATMENT FOR MENTAL DISORDERS IN METHADONE CLINICS IN UKRAINENIDA2018–2023
Integrating HIV, TB and Addiction Treatment in Primary Care Clinics in UkraineNational Institute on Drug Abuse2016–2023
Prison Interventions and HIV Prevention CollaborationNIDA2010–2023
Integrated rapid access to HIV prevention program for people who inject drugs (iRaPID)NIDA2020–2022
Developing an Artificial Intelligence Chatbot to Promote HIV TestingNIAID2020–2022
Addiction, HIV and TB in Malaysian PrisonsNIDA2016–2022
Expanding Medication Assisted Therapies In UkraineNational Institute On Drug Abuse2012
Naltrexone For Opioid Dependent Released HIV+ Criminal Justice PopulationsNational Institute On Drug Abuse2010–2011
HIV, Buprenorphine, And The Criminal Justice SystemNational Institute On Drug Abuse2010–2011
Alcohol Pharmacotherapies Among Released PrisonersNational Institute On Alcohol Abuse And Alcoholism2009–2011
Intervention Of HIV, Drug Use And The Criminal Justice System In MalaysiaNational Institute On Drug Abuse2008–2011
Project ChoicesCenter For Substance Abuse Treatment2008–2011
Enhancing Health Outcomes Among HIV+ Substance AbusersNational Institute On Drug Abuse2003–2011
Directly Observed Therapy For Community-Released Hiv-Positive PrisonersNational Institute On Drug Abuse2007–2008
Ps06-011, HIV Prevention Research With HIV+ Incarcerated PopulationsNational Center For Hiv, Viral Hepatitis, Stds And Tb Prevention2007
Improving Health Outcomes For Released HIV+ PrisonersNational Institute On Drug Abuse2006–2007
HIV Prevention Research With HIV+ Incarcerated PopulationsNational Center For Hiv, Viral Hepatitis, Stds And Tb Prevention2006
Direct/Observed Therapy/Community-Released Hiv+PrisonersNational Institute On Drug Abuse2004–2006
Directly Observed Anti Retroviral Therapy Among Active DNational Institute On Drug Abuse2000–2004
Provision Of Needle Exchange Based Health ServicesNational Institute On Drug Abuse1995–1999